Evidence map›Paper›PMID 10225873›Full record

ArticleInfection and immunity1999

Cytoskeletal effects induced by pet, the serine protease enterotoxin of enteroaggregative Escherichia coli.

F Navarro-García, C Sears, C Eslava, A Cravioto, J P Nataro

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
3.6field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 121 citations in OpenAlex.

  1. EnteroaggregativeEcoSal Plus · 2025
    Review
  2. Plasmid-encoded toxin ofFrontiers in cellular and infection microbiology · 2024
    Article
  3. Article
  4. Review
  5. The journal of venomous animals and toxins including tropical diseases · 2021
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Applied and environmental microbiology · 2019
    Article
  11. Curcumin Blocks Cytotoxicity of Enteroaggregative and EnteropathogenicFrontiers in cellular and infection microbiology · 2019
    Article
  12. Characterization of Diarrheagenic EnteroaggregativeFrontiers in cellular and infection microbiology · 2018
    Article
  13. Identification of Subsets of EnteroaggregativeThe American journal of tropical medicine and hygiene · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

F Navarro-GarcíaCenter for Vaccine Development, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA. fnavarro@servidor.unam.mx
C Sears
C Eslava
A Cravioto
J P Nataro
Universidad Nacional Autónoma de México · MXUniversity of Maryland, Baltimore · USJohns Hopkins Medicine · US

Funding

Virulence in Enteroaggregative Escherichia coliR01AI033096 · NIAID · UNIVERSITY OF VIRGINIA · PI NATARO, JAMES P. · 1996 to 2014
$6.6M
ADHERENCE IN ENTEROAGGREGATIVE E. COLIR29AI033096 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI NATARO, JAMES P. · 1992 to 1996
–
FIC NIH HHS TW00499NIAID NIH HHS AI33096NIAID NIH HHS R01 AI033096
6 · The paper itself

Abstract

We have previously described enteroaggregative Escherichia coli (EAEC) strains that induce cytotoxic effects on T84 cells, ligated rat ileal loops, and human intestine in culture. Such strains secrete a 104-kDa protein termed Pet (for plasmid-encoded toxin). We have also shown previously that the Pet toxin induces rises in short-circuit current and decreases the electrical resistance in rat jejunum mounted in an Ussing chamber. The nucleotide sequence of the pet gene revealed that Pet is a member of the autotransporter class of secreted proteins. Here we show that a concentrated supernatant of E. coli HB101 harboring the minimal pet clone pCEFN1 induces temperature-, time- and dose-dependent cytopathic effects on HEp-2 cells and HT29 C1 cells in culture. The effects were characterized by release of the cellular focal contacts from the glass substratum, followed by complete rounding of the cells and detachment from the glass. Staining of the Pet-treated cells with Live/Dead viability stain revealed that >90% of rounded cells were viable. Pet-intoxicated HEp-2 and HT29 cells stained with fluorescein-labeled phalloidin revealed contraction of the cytoskeleton and loss of actin stress fibers. However, the effects of Pet were not inhibited by cytoskeleton-altering drugs, including colchicine, taxol, cytochalasin D, and phallicidin. The Pet protein induced proteolysis in zymogram gels, and preincubation with the serine protease inhibitor phenylmethylsulfonyl fluoride resulted in complete abrogation of Pet cytopathic effects. We introduced a mutation in a predicted catalytic serine residue and found that the mutant (Pet S260I) was deficient in protease activity and did not produce cytopathic effects, cytoskeletal damage, or enterotoxic effects in Ussing chambers. These data suggest that Pet is a cytoskeleton-altering toxin and that its protease activity is involved in each of the observed phenotypes.

Indexed as

AnimalsBacterial ToxinsBase SequenceCell LineCytoskeletonDNA PrimersEnterotoxinsEscherichia coliHT29 CellsHumansIn Vitro TechniquesMutagenesis, Site-DirectedMutationPhenotypeRatsSerine EndopeptidasesBacterial ToxinsDNA PrimersEnterotoxinsSerine Endopeptidases

Identifiers

PMID10225873
PMCPMC115956
OpenAlexW2168695460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.